Chris Ehrlich

Mr. Chris Ehrlich is CERo Therapeutics’ current Chief Executive Officer.  He brings extensive experience in biotechnology, business development, venture capital, investment banking, and SPACs.  He currently also serves as the CEO of Launch One Acquisition Corp.  He previously served as the CEO of Phoenix Biotech Acquisition Corp. and Locust Walk Acquisition Corp. He was also a Senior Managing Director at Locust Walk Partners, where he was involved with sourcing and leading multiple transactions for emerging biopharmaceutical companies, including the sale of Xyphos Biosciences, Inc. to Astellas in 2019 and the sale of Thar Pharmaceuticals to Grunenthal in 2018. Prior to Locust Walk Partners, he was a Managing Director at InterWest Partners (“InterWest”), a venture capital firm.